How to check a compounding pharmacy making semaglutide: its FDA and state records

How can I check a compounding pharmacy making semaglutide?

Check three public records: the pharmacy’s license with the state board of pharmacy where it is located and in your state (FDA’s BeSafeRx page links every board), FDA’s compounding inspections and actions page, which lists 399 pharmacies and outsourcing facilities with 1,292 dated Form 483s, warning letters and other actions (current as of Oct 22, 2026), and for an outsourcing facility, FDA’s 503B list of 100 registered facilities (Nov 6, 2026). None of these records rates a pharmacy’s products, and FDA states that compounded drugs are not FDA-approved.

This page explains where records live. It does not rate pharmacies.

Steps

  1. Get the pharmacy’s exact legal name, any “doing business as” name and street address. A telehealth company should name the pharmacy that fills the prescription.
  2. State license: look the pharmacy up with the board of pharmacy in its home state, and in your state if it ships to you. Licenses are state records; this site does not hold them.
  3. FDA inspections and letters: find the pharmacy on FDA’s compounding inspections and actions list, which shows each Form 483, warning letter and close-out FDA has posted since 2019. A pharmacy FDA has not inspected or acted on will not appear.
  4. 503B registration: if the pharmacy says it is an outsourcing facility, it should be on FDA’s registered outsourcing facility list. See how to check 503B registration.
  5. GLP-1 records: search this index for warning letters and recalls naming semaglutide or tirzepatide, or read how to find FDA warning letters for a compounding pharmacy.

Public lookup pages

LookupWhat it shows
FDA BeSafeRx: Locate a state-licensed online pharmacyFDA’s page listing each state board of pharmacy, where you can confirm a pharmacy holds a license in your state.
NABP Safe.PharmacyThe National Association of Boards of Pharmacy’s public site for looking up whether a pharmacy website is accredited or listed as not recommended by NABP.
LegitScript website certification statusLegitScript’s public lookup of whether a website holds LegitScript certification, a private certification that payment and ad platforms use.
FDA warning letters databaseFDA’s searchable index of every posted warning letter. Search the company name and any brand or website name.
FDA Internet pharmacy warning lettersFDA’s list of warning letters sent to online pharmacies and websites.
FDA Registered Outsourcing Facilities (503B)FDA’s weekly list of registered 503B outsourcing facilities with last inspection dates and Form 483 status.
FDA: Compounding: Inspections, Recalls, and other ActionsFDA’s A to Z list of compounding pharmacies and outsourcing facilities with each dated Form 483, warning letter, close-out and referral letter since 2019.

Compounders with GLP-1 recall reports

ProRx LLC14
AEQUITA PHARMACY13
Apollo Care, LLC11
Carolina Infusion, LLC11
Thrive Health and Wellness, LLC8
GenoGenix LLC4
New Life Pharma LLC4
Boothwyn Pharmacy LLC3
Harbin Jixianglong Biotech Co., Ltd.2
Pharmacy Plus, Inc. dba Vital Care Compounder2
Revive Rx LLC dba Revive Rx Pharmacy2
TMC Acquisition LLC dba Tailor Made Compounding2
Apothecary Pharma LLC1
Houston Rx LLC1
PAYLESS COMPOUNDERS, LLC1
Pharmacy Innovations1
TMC Acquisitions LLC dba Tailor Made Compounding1

Common questions

How do I verify a telehealth company’s pharmacy is licensed to ship GLP-1s to my state?

Ask the telehealth company for the dispensing pharmacy’s legal name and address, then search it on your state board of pharmacy’s license lookup; FDA’s BeSafeRx page links each board. This index matches pharmacy pages to state board license files for California, Colorado, Connecticut, Delaware, Florida, Illinois, Michigan and Texas only; see each pharmacy page.

What does it mean if a pharmacy is on FDA’s compounding actions list?

That FDA inspected it or took an action, such as a Form 483, warning letter, untitled letter or state referral, and posted it. A Form 483 lists observations and is not a final agency determination; a close-out letter means FDA completed its review of the firm’s corrective actions.

Is a pharmacy that is not on the list unchecked?

Not necessarily. 503A pharmacies are licensed by states, and FDA’s list covers only actions FDA posted from 2019 on. Absence from the list is not a finding either way.

Sources

Records last pulled Nov 15, 2026. Every entry links to the original public record.